Allan L. Goldstein

12.5k total citations
282 papers, 9.8k citations indexed

About

Allan L. Goldstein is a scholar working on Immunology, Molecular Biology and Cell Biology. According to data from OpenAlex, Allan L. Goldstein has authored 282 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Immunology, 77 papers in Molecular Biology and 67 papers in Cell Biology. Recurrent topics in Allan L. Goldstein's work include Cellular Mechanics and Interactions (63 papers), T-cell and B-cell Immunology (30 papers) and Monoclonal and Polyclonal Antibodies Research (28 papers). Allan L. Goldstein is often cited by papers focused on Cellular Mechanics and Interactions (63 papers), T-cell and B-cell Immunology (30 papers) and Monoclonal and Polyclonal Antibodies Research (28 papers). Allan L. Goldstein collaborates with scholars based in United States, Italy and France. Allan L. Goldstein's co-authors include Teresa L. K. Low, Hynda K. Kleinman, Abraham White, Paul H. Naylor, Gary B. Thurman, Mahnaz Badamchian, John E. McClure, Marion M. Zatz, Katherine M. Malinda and Ewald Hannappel and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Allan L. Goldstein

277 papers receiving 8.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan L. Goldstein United States 51 3.0k 3.0k 2.3k 1.2k 1.1k 282 9.8k
Paul K. Nakane Japan 44 2.1k 0.7× 5.2k 1.8× 1.2k 0.5× 1.4k 1.1× 1.1k 1.1× 146 12.6k
Renato Longhi Italy 52 1.5k 0.5× 3.9k 1.3× 761 0.3× 623 0.5× 890 0.8× 210 8.2k
W. M. Hunter United Kingdom 29 1.5k 0.5× 4.7k 1.6× 925 0.4× 2.2k 1.8× 1.1k 1.0× 87 11.7k
Samuel C. Silverstein United States 52 3.8k 1.2× 4.1k 1.4× 1.0k 0.5× 714 0.6× 655 0.6× 108 11.5k
Luigi Frati Italy 63 4.0k 1.3× 6.5k 2.2× 885 0.4× 852 0.7× 3.5k 3.2× 448 14.8k
Oddmund Bakke Norway 45 4.0k 1.3× 3.4k 1.2× 1.8k 0.8× 629 0.5× 742 0.7× 135 7.9k
Klaus Pfizenmaier Germany 69 7.5k 2.4× 7.9k 2.7× 1.3k 0.6× 1.3k 1.1× 3.1k 2.8× 253 17.3k
William F. Hickey United States 62 4.9k 1.6× 3.8k 1.3× 591 0.3× 865 0.7× 1.7k 1.6× 190 15.6k
Pam Fredman Sweden 51 1.4k 0.5× 4.3k 1.5× 1.1k 0.5× 799 0.7× 558 0.5× 177 8.0k
Ruth Arnon Israel 59 3.7k 1.2× 3.6k 1.2× 414 0.2× 2.0k 1.7× 1.2k 1.1× 283 10.9k

Countries citing papers authored by Allan L. Goldstein

Since Specialization
Citations

This map shows the geographic impact of Allan L. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan L. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan L. Goldstein more than expected).

Fields of papers citing papers by Allan L. Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan L. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan L. Goldstein. The network helps show where Allan L. Goldstein may publish in the future.

Co-authorship network of co-authors of Allan L. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Allan L. Goldstein. A scholar is included among the top collaborators of Allan L. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan L. Goldstein. Allan L. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Renga, Giorgia, Marina Maria Bellet, Marilena Pariano, et al.. (2020). Thymosin α1 protects from CTLA-4 intestinal immunopathology. Life Science Alliance. 3(10). e202000662–e202000662. 21 indexed citations
2.
Renga, Giorgia, Vasileios Oikonomou, Silvia Moretti, et al.. (2019). Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease. Life Science Alliance. 2(6). e201900432–e201900432. 14 indexed citations
3.
Stincardini, Claudia, Giorgia Renga, Valeria Rachela Villella, et al.. (2018). Cellular proteostasis: a new twist in the action of thymosin α1. Expert Opinion on Biological Therapy. 18(sup1). 43–48. 7 indexed citations
4.
Romani, Luigina, Vasileios Oikonomou, Silvia Moretti, et al.. (2017). Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nature Medicine. 23(5). 590–600. 77 indexed citations
5.
Goldstein, Allan L., et al.. (2007). Thymosins in health and disease : international symposium. 1 indexed citations
6.
Rubin, Bruce K., Arnon P. Kater, & Allan L. Goldstein. (2006). Thymosin β4 Sequesters Actin in Cystic Fibrosis Sputum and Decreases Sputum Cohesivity in Vitro. CHEST Journal. 130(5). 1433–1440. 20 indexed citations
7.
Palmer, Douglas C., Sanjeeve Balasubramaniam, Ken‐ichi Hanada, et al.. (2004). Vaccine-Stimulated, Adoptively Transferred CD8+ T Cells Traffic Indiscriminately and Ubiquitously while Mediating Specific Tumor Destruction. The Journal of Immunology. 173(12). 7209–7216. 97 indexed citations
8.
Sosne, Gabriel, et al.. (2004). Thymosin beta 4 Expression In Corneal Wound Healing. Investigative Ophthalmology & Visual Science. 45(13). 1425–1425. 2 indexed citations
9.
Moody, Terry W., Julius Leyton, Farah Zia, et al.. (2000). Thymosinα1 is chemopreventive for lung adenoma formation in A/J mice. Cancer Letters. 155(2). 121–127. 18 indexed citations
10.
Malinda, Katherine M., Hynda K. Kleinman, Gurmel S. Sidhu, et al.. (1999). Thymosin β4 Accelerates Wound Healing. Journal of Investigative Dermatology. 113(3). 364–368. 246 indexed citations
11.
Goldstein, Allan L., et al.. (1995). Combination therapies 2. Biological response modifiers in the treatment of cancer and infectious diseases. General Pharmacology The Vascular System. 26(3). 656–657. 10 indexed citations
12.
Sarin, Prem S., Paul H. Naylor, Jeffrey Kahn, et al.. (1994). Cytotoxic and humoral immune responses to HIV-1 p17 synthetic peptide HGP-30 in human volunteers. 3(1). 49–57. 1 indexed citations
13.
Sherman, Kenneth E., et al.. (1991). Low Thymosin Alpha-1 Concentrations in Patients Chronically Infected with the Hepatitis B Virus*. Viral Immunology. 4(3). 195–199. 22 indexed citations
14.
Goldstein, Allan L., et al.. (1988). Enzyme immunoassay measurement of thymosin beta 4 in human serum.. PubMed. 7(1). 91–6. 16 indexed citations
15.
Low, Teresa L. K. & Allan L. Goldstein. (1985). [13] Thymic hormones: An overview. Methods in enzymology on CD-ROM/Methods in enzymology. 116. 213–219. 40 indexed citations
16.
Low, Teresa L. K. & Allan L. Goldstein. (1984). Thymosins: structure, function and therapeutic applications.. PubMed. 6(1-2). 27–42. 82 indexed citations
17.
Naylor, Paul H. & Allan L. Goldstein. (1983). Abnormally elevated thymosin α1 levels in the acquired immunodeficiency syndrome (AIDS). Clinical Immunology Newsletter. 4(9). 126–128. 4 indexed citations
18.
Fefer, Alexander & Allan L. Goldstein. (1982). The Potential role of T cells in cancer therapy. Raven Press eBooks. 47 indexed citations
19.
Huang, Kun-Yen, Phyllis D. Kind, Elaine M. Jagoda, & Allan L. Goldstein. (1981). Thymosin Treatment Modulates Production of Interferon. Journal of Interferon Research. 1(3). 411–420. 44 indexed citations
20.
Goldstein, Allan L., et al.. (1972). Some Effects of Nitrogen Sources, Vitamins, and Temperature on the Swelling Phase of Dimargaris Verticillata Spore Germination. Mycologia. 64(5). 1118–1123. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul K. Nakane Breakdown of academic impact, for papers by Renato Longhi Breakdown of academic impact, for papers by W. M. Hunter Breakdown of academic impact, for papers by Samuel C. Silverstein Breakdown of academic impact, for papers by Luigi Frati Breakdown of academic impact, for papers by Oddmund Bakke Breakdown of academic impact, for papers by Klaus Pfizenmaier Breakdown of academic impact, for papers by William F. Hickey Breakdown of academic impact, for papers by Pam Fredman Breakdown of academic impact, for papers by Ruth Arnon
Rankless by CCL
2026